Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections

Journal of Clinical Virology

Volumn 42, Issue 1, 2008, Pages 22-26

  Baleriola, Cristina ^a   Millar, Douglas ^b   Melki, John ^b   Coulston, Neralie ^b   Altman, Phillip ^c   Rismanto, Nikolas ^a   Rawlinson, William ^a  

^a New South Wales Government   (Australia)

^b Human Genetic Signatures   (Australia)

^c Altman Biomedical Consulting Pty Ltd Australia   (Australia)

Author keywords

Cervical cancer; Diagnostic methods; Human papillomavirus (HPV); PCR

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIGENE HYBRID CAPTURE II ASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION RISK; INTERMETHOD COMPARISON; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STANDARD; UTERINE CERVIX; VERRUCA VULGARIS; VIRUS STRAIN; WART VIRUS;

AUSTRALIA; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 42649138888     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.12.008     Document Type: Article

References (36)

1. Albrecht V., Chevallier A., Magnone V., Barbry P., Vandenbos F., Bongain A., et al. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays. J Virol Methods 137 2 (2006) 236-244
2. An H.J., Cho N.H., Lee S.Y., Kim I.H., Lee C., Kim S.J., Mun M.S., Kim S.H., and Jeong J.K. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97 (2003) 1672-1680
3. Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective international biological study on cervical cancer. J Natl Cancer Inst 87 (1995) 796-802
4. Chacón J., Sanz I., Rubio M.D., De la Morena M.L., Díaz E., Mateos M.L., et al. Detection and genotyping of high-risk human papillomavirus in cervical specimens. Enferm Infect Microbiol Clin 25 5 (2007) 311-316
5. Clavel C., Masure M., Putaud I., Thomas K., Bory J.P., Gabriel R., et al. Hybrid capture II, a new sensitive test for human papillomavirus detection Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 51 (1998) 737-740
6. Clavel C., Masure M., Levert M., Putaud I., Manjeonjean C., Lorenzato M., et al. Human papillomavirus detection by the Hybrid Capture assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol 9 (2000) 145-150
7. Clifford G.M., Smith J.S., Plummer M., Muñoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 (2003) 63-73
8. Coutlée F., et al. Use of PGMY Primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40 (2002) 902-907
9. Cuschieri K.S., Whitley M.J., and Cubie H.A. Human papillomavirus type specific DNA and RNA persistence-implications for cervical disease progression and monitoring. J Med Virol 73 (2004) 65-70
10. Del Mistro A., Salamanca H.F., Trevisan R., Bertorelle R., Parenti A., Bonoldi E., et al. Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer 1 (2006) 9
11. Fontaine V., Mascaux C., Weyn C., Bernis A., Celio N., Lefèvre P., et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol 45 3 (2007) 928-934
12. Gheit T., Landi S., Gemignani F., Snijders P.J., Vaccarella S., Franceschi S., et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 44 6 (2006) 2025-2031
13. Giovannelli L., Lama A., Capra G., Giordano V., Arico P., and Ammatuna P. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol 42 8 (2004) 3861-3864
14. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutléee F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38 (2000) 357-361
15. Josefsson A.M., Magnusson P.K., Ylitalo N., et al. Viral load of human papillomvirus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189
16. Kornegay J.R., Roger M., Davies P.O., Shepard A.P., Guerrero N.A., Lloveras B., et al. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol 41 (2003) 1080-1086
17. Kulmala S.-M., Syrjänen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J., et al., NIS Cohort Study Group. Human papillomavirus testing with the Hybrid Capture 2 assay and PCR as screening tools. J Clin Microbiol 42 (2004) 2470-2475
18. Lai C.H., Chang C.J., Huang H.J., Hsueh S., Chao A., Yang J.E., et al. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. J Clin Oncol 25 (2007) 3628-3634
19. Leisenring W., Alonzo T., and Pepe M.S. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 56 (2000) 345-351
20. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinsky S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7 (1989) 209-214
21. Moskowitz C.S., and Pepe M.S. Comparing the predictive values of diagnostic tests: sample size and analysis for pair study designs. Clin Trials 3 (2006) 272-279
22. Muldrew K.L., Beqaj S.H., Han J., Lum S.H., Clinard V., Schultenover S.J., et al. Evaluation of a Digene-recommended algorithm for human papillomavirus low-positive results present in a "retest zone". Am J Clin Pathol 127 1 (2007) 97-102
23. Nelson J.H., Hawkins G.A., Edlung K., Evander M., Kjellberg L., Wadell G., et al. Rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol 38 (2000) 688-695
24. Oh Y., Bae S.M., Kim Y.W., Choi H.S., Nam G.H., Han S.J., et al. Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. Cancer Sci 98 4 (2007) 549-554
25. Pilch H., Günzel S., Schäffer U., Tanner B., Brockerhoff P., Maeurer M., et al. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes-correlation with clinico-pathological parameters and prognostic significance. Zentralbl Gynakol 123 (2001) 91-101
26. Poljak M., Brencic A., Seme K., Vince A., and Marin I.J. Comparative evaluation of first and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J Clin Microbiol 37 3 (1999) 796-797
27. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 Suppl 3 (2002) S89-S97
28. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y.F., Klein R.S., et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP51/GP61 Primer Systems. J Clin Mirobiol 35 (1997) 1304-1310
29. Schwartz S.M., Daling J.R., Shera K.A., Madeleine M.M., McKnight B., Galloway D.A., et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 19 (2001) 1906-1915
30. Seme K., Fujs K., Kocjan B.J., and Poljak M. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods 134 1/2 (2006) 252-256
31. Snliders P.J.F., Van Den Brule A.J.C., Schrijnemakers H.F.J., Snow G., Meijer C.J.L.M., and Walboomers J.M.M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71 (1990) 173-181
32. Soderlund-Strand A., Rymark P., Andersson P., Dillner J., and Dillner L. Comparison between the Hybrid Capture II Test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J Clin Microbiol 43 (2005) 3260-3266
33. Sotlar K., Diemer D., Dethleffs A., Hack Y., Stubner A., Vollmer N., et al. Detection and typing of human papillomavirus by E6 Nested Multiplex PCR. J Clin Microbiol 42 (2004) 3176-3184
34. van Doorn L.J., Molijn A., Kleter B., Quint W., and Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 44 September 9 (2006) 3292-3298
35. Workowski K.A., and Berman S.M. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 55 (2006) 1
36. Wright T.C., Shiffman M., Solomon D., Cox J.T., García F., Goldie S., et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103 (2004) 304-309